ClinicalTrials.Veeva

Menu

Teicoplanin Prophylaxis for Total Hip or Knee Arthroplasty

N

National and Kapodistrian University of Athens

Status and phase

Completed
Phase 4

Conditions

Total Hip and Knee Arthroplasties

Treatments

Drug: Teicoplanin
Drug: β-lactams or ciprofloxacin

Study type

Interventional

Funder types

Other

Identifiers

NCT00719056
TEICO01

Details and patient eligibility

About

This is a prospective, open-label, randomized clinical trial where patients were administered prophylaxis for total hip or knee arthroplasty either with teicoplanin or with other antibiotics. The study is aiming to evaluate any differences between these two different strategies of antimicrobial prophylaxis in the occurrence of surgical site infections

Full description

This is a prospective, open-label, randomized clinical trial where patients were administered prophylaxis for total hip or knee arthroplasty either with a single dose of teicoplanin or with multiple doses of other antibiotics according to the habits of the attending physicians aiming to evaluate any differences between these two different strategies of antimicrobial prophylaxis in the occurrence of surgical site infections

Enrollment

616 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients admitted for total hip arthroplasty
  • Patients admitted for total knee arthroplasty

Exclusion criteria

  • Revision arthroplasty
  • History of any infection within the preceding two months
  • History of an operation in the same hip or knee for other causes
  • Known history of allergy to the studied drug
  • Pregnancy or lactation
  • Any antibiotic therapy in the week before operation.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

616 participants in 2 patient groups

1
Experimental group
Description:
Surgical chemoprophylaxis of one dose of teicoplanin upon introduction of anesthesia for total hip or knee arthroplasty.
Treatment:
Drug: Teicoplanin
2
Active Comparator group
Description:
Surgical chemoprophylaxis with multiple dose of other antimicrobials for up to six consecutive days for total hip or knee arthroplasty.
Treatment:
Drug: β-lactams or ciprofloxacin

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems